OIG ramps up Medicaid fraud efforts
The HHS Office of the Inspector General will increase its presence in the Medicaid fraud arena, Inspector Thomas Sowinski said at a RAPS conference held in Denver May 1-2. Congress recently authorized the agency a "decent" sum of money to hire approximately 30 more agents to be specifically assigned to Medicaid related cases, he said, noting that previously, "we were very limited in the drug cases that we would work." He also said that Part D may increase Medicare fraud investigations. "You are going to see cases that could deal with the formularies for the drug plans, if drug companies or others are enticing them to include their drug on a formulary for another reason than just an effective drug, that might be something we are going to investigate"...
You may also be interested in...
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."